Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Vineet Laboratories Limited

Market Cap 558M 5.87M 5.07M 4.67M 4.37M 8.2M 8.33M 55.18M 21.52M 272M 22.04M 21.57M 941M P/E Ratio 2024
43.6x
P/E Ratio 2025 -1.42x
Enterprise Value 956M 10.05M 8.68M 8M 7.49M 14.04M 14.25M 94.48M 36.83M 465M 37.73M 36.93M 1.61B EV / Sales 2024
587,502x
EV / Sales 2025 890,202x
Free-Float
62.66%
Yield 2024 *
-
Yield 2025 -
1 day-1.54%
1 week-2.30%
1 month-1.96%
3 months+15.58%
6 months-20.89%
Current year-7.64%
1 week 33.06
Extreme 33.06
34.9
1 month 32.76
Extreme 32.76
37.4
Current year 27.96
Extreme 27.96
43.5
1 year 27.96
Extreme 27.96
49.99
3 years 26.51
Extreme 26.51
88.9
5 years 26.51
Extreme 26.51
124
10 years 26.51
Extreme 26.51
124
Manager TitleAgeSince
Chief Executive Officer 56 2016-11-09
Director of Finance/CFO 76 2020-12-31
Human Resources Officer - -
Director TitleAgeSince
Director/Board Member 56 2016-11-09
Director/Board Member 76 2016-11-09
Chairman 73 2020-11-15
Change 5-day change 1-year change 3-year change Capi.($)
-1.54%-2.30%+13.23%-34.04% 6.86M
-2.41%+0.14%+38.28%+154.20% 1,010B
+1.07%+3.48%+53.32%+49.85% 580B
+1.32%+0.22%+19.18%+64.65% 402B
+0.77%0.00%+21.28%+16.70% 330B
+0.44%+3.48%+25.65%+35.66% 281B
-0.85%-2.86%+22.54%+14.67% 280B
+1.66%+1.20%-44.35%-47.35% 197B
+0.32%+1.61%+20.32%+60.01% 192B
-0.22%-2.76%+14.19%+60.09% 156B
Average +0.06%+0.53%+18.36%+37.44% 342.89B
Weighted average by Cap. -0.23%+1.04%+27.77%+70.54%

Financials

2024 2025
Net sales 1.51K 15.88 13.72 12.64 11.83 22.17 22.52 149.26 58.2 734.8 59.61 58.34 2.54K 769.53 8.1 6.99 6.44 6.03 11.3 11.48 76.08 29.66 374.56 30.38 29.74 1.3K
Net income 10.27M 108K 93.33K 86K 80.5K 151K 153K 1.02M 396K 5M 406K 397K 17.31M -202M -2.12M -1.83M -1.69M -1.58M -2.97M -3.01M -19.96M -7.78M -98.28M -7.97M -7.8M -340M
Net Debt 441M 4.64M 4M 3.69M 3.45M 6.47M 6.57M 43.57M 16.99M 215M 17.4M 17.03M 743M 397M 4.18M 3.61M 3.33M 3.11M 5.84M 5.93M 39.29M 15.32M 193M 15.69M 15.36M 670M
Logo Vineet Laboratories Limited
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Employees
57
Date Price Change Volume
26-06-12 33.97 -1.54% 35,451
26-06-11 34.50 +3.76% 20,821
26-06-10 33.25 -1.36% 10,060
26-06-09 33.71 +0.96% 13,503
26-06-08 33.39 -3.97% 41,251
  1. Stock Market
  2. Stocks
  3. VINEETLAB Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!